Intravenous cyclosporin in ulcerative colitis: A five-year experience

American Journal of Gastroenterology

Volumn 94, Issue 6, 1999, Pages 1587-1592

  Cohen, Russell D ^a   Stein, Robert ^a   Hanauer, Stephen B ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; MERCAPTOPURINE; STEROID;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLON RESECTION; CONTROLLED STUDY; DISEASE SEVERITY; ELECTROLYTE DISTURBANCE; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; LUNG ABSCESS; MALE; MEDICAL RECORD; ORAL DRUG ADMINISTRATION; PARESTHESIA; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT OUTCOME; ULCERATIVE COLITIS;

6-MERCAPTOPURINE; ADOLESCENT; ADULT; AGED; AZATHIOPRINE; CHILD; COLECTOMY; COLITIS, ULCERATIVE; CYCLOSPORINE; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RETREATMENT; STEROIDS; TREATMENT OUTCOME;

EID: 0033013272     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1999.01149.x     Document Type: Article

References (10)

1. Sandborn W.J. A critical review of cyclosporin therapy in inflammatory bowel disease. Inflamm Bowel Dis. 1:1995;48-63.
2. Actis G.C., Ottobrelli A., Pera A., et al. Continuously infused cyclosporine at low dose is sufficient to avoid emergency colectomy in acute attacks of ulcerative colitis without the need for high-dose steroids. J Clin Gastroenterol. 17:1993;10-13.
3. Lichtiger S., Present D.H., Kornbluth A., et al. Cyclosporin in severe ulcerative colitis refractory to steroid therapy. N Engl J Med. 330:1994;1841-1845.
4. Kornbluth A., Lichtiger S., Present D., et al. Long-term results of oral cyclosporin in patients with severe ulcerative colitis A double-blind, randomized, multi-center trial . Gastroenterology. 106:1994;A714.
5. Cohen R.D., Brodsky A.L., Hanauer S.B. A comparison of the quality of life in patients with severe ulcerative colitis after total colectomy versus medical treatment with intravenous cyclosporin. Inflamm Bowel Dis. 5:1999;1-10.
6. Baert F., Hanauer S. CYA in severe steroid-resistant UC Long-term results of therapy . Gastroenterology. 106:1994;A648.
7. Sternthal M., George J., Kornbluth A., et al. Toxicity associated with the use of cyclosporin in patients with inflammatory bowel disease (IBD). Gastroenterology. 110:1996;A1019.
8. Adler D.J., Korelitz B.I. The therapeutic efficacy of 6-mercaptopurine in refractory ulcerative colitis. Am J Gastroenterol. 85:1990;717-722.
9. Hawthorne A.B., Logan R.F., Hawkey C.J., et al. Randomised controlled trial of azathioprine withdrawal in ulcerative colitis. Br Med J. 305:1992;20-22.
10. George J., Present D.H., Pou R., et al. The long-term outcome of ulcerative colitis treated with 6-mercaptopurine. Am J Gastroenterol. 91:1996;1711-1714.